Pharmacological Mechanisms in Alzheimer's Therapeutics (eBook, PDF)
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Pharmacological Mechanisms in Alzheimer's Therapeutics (eBook, PDF)
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
- Geräte: PC
- eBook Hilfe
Andere Kunden interessierten sich auch für
Produktdetails
- Produktdetails
- Verlag: Springer New York
- Erscheinungstermin: 22. Dezember 2007
- Englisch
- ISBN-13: 9780387715223
- Artikelnr.: 37287865
- Verlag: Springer New York
- Erscheinungstermin: 22. Dezember 2007
- Englisch
- ISBN-13: 9780387715223
- Artikelnr.: 37287865
Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets.- Trial Designs and Outcomes to Monitor Novel Therapeutics in Alzheimer's Disease.- The Pharmacological Treatment of Alzheimer's Disease with Cholinesterase Inhibitors and Memantine.- M1 Muscarinic Agonists: A Comprehensive Therapy Against Major Hallmarks of Alzheimer's Disease.- Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy.- The Rationale for Glutamatergic Therapy in Alzheimer's Disease.- Secretases as Pharmacological Targets in Alzheimer's Disease.- ?-Secretase as a Target for Alzheimer's Disease.- The Rationale for an Immunological Approach to Alzheimer's Therapeutics.- Neuroinflammation, Alzheimer Disease, and Other Aging Disorders.- Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Derived A?42-Lowering Molecules for Treatment and Prevention of Alzheimer's Disease (AD).- The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics.- Apolipoprotein E: A Potent Gene-Based Therapeutic Target for the Treatment of Sporadic Alzheimer's Disease.- Tau Pathology as a Target in Alzheimer's Therapeutics.- Design of Inhibitors of Amyloid-? Misfolding and Aggregation for Alzheimer's Therapy.- Potential Applications of Glycosaminoglycan-Related Compounds in Alzheimer's Disease.- Multifunctional Neuroprotective Drugs for the Treatment of Alzheimer's Disease.- Interpreting Clinical Studies of Putative Therapeutics for Alzheimer's Disease: The Case of Statins and NSAIDs.
Overview of the Alzheimer's Disease Pathology and Potential Therapeutic Targets.- Trial Designs and Outcomes to Monitor Novel Therapeutics in Alzheimer's Disease.- The Pharmacological Treatment of Alzheimer's Disease with Cholinesterase Inhibitors and Memantine.- M1 Muscarinic Agonists: A Comprehensive Therapy Against Major Hallmarks of Alzheimer's Disease.- Cholinergic Neurodegeneration in Alzheimer's Disease: Basis for Nerve Growth Factor Therapy.- The Rationale for Glutamatergic Therapy in Alzheimer's Disease.- Secretases as Pharmacological Targets in Alzheimer's Disease.- ?-Secretase as a Target for Alzheimer's Disease.- The Rationale for an Immunological Approach to Alzheimer's Therapeutics.- Neuroinflammation, Alzheimer Disease, and Other Aging Disorders.- Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and Derived A?42-Lowering Molecules for Treatment and Prevention of Alzheimer's Disease (AD).- The Potential Application of Antioxidant Agents in Alzheimer Disease Therapeutics.- Apolipoprotein E: A Potent Gene-Based Therapeutic Target for the Treatment of Sporadic Alzheimer's Disease.- Tau Pathology as a Target in Alzheimer's Therapeutics.- Design of Inhibitors of Amyloid-? Misfolding and Aggregation for Alzheimer's Therapy.- Potential Applications of Glycosaminoglycan-Related Compounds in Alzheimer's Disease.- Multifunctional Neuroprotective Drugs for the Treatment of Alzheimer's Disease.- Interpreting Clinical Studies of Putative Therapeutics for Alzheimer's Disease: The Case of Statins and NSAIDs.